科研项目详细信息
Inhibition of small-conductance Ca2+-activated potassium (SK) channel as a novel concept for the treatment of atrial fibrillation | |
Dr Morten Grunnet | |
Acesion Pharma | |
Subject:医学(综合) | |
2015至2015 | |
Source: 英国惠康基金会 | |
Link: https://wellcome.org/grant-funding/funded-people-and-projects |